Drug · DIN 02281074
ACZONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 4, 2020; first marketed October 21, 2011.
- Drug Identification Number (DIN)
- 02281074
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Dapsone D10AX05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAPSONE | 5 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 4, 2020: NOC 23723New Drug Submission (NDS) · Administrative: Change in Product Ownership
- June 2, 2011: NOC 12390New Drug Submission (NDS) · Manufacturer name change
- November 4, 2008: NOC 9868New Drug Submission (NDS) · Manufacturer name change
- June 15, 2006: NOC 8028New Drug Submission (NDS)